|
|
ear development
|
GO:0043583 |
200 |
0.574
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.470
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.391
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.372
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.359
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.325
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.317
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.313
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.309
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.292
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.284
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.270
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.268
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.259
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.257
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.256
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.250
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.239
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.236
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.232
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.226
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.224
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.218
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.209
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.209
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.207
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.205
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.204
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.203
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.203
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.201
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.201
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.199
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.197
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.192
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.192
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.187
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.185
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.185
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.184
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.184
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.183
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.181
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.181
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.180
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.178
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.177
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.177
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.175
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.172
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.172
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.170
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.168
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.166
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.165
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.165
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.163
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.163
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.159
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.158
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.158
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.157
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.156
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.154
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.153
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.152
|
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.152
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.151
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.151
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.150
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.150
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.149
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.147
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.147
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.147
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.141
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.140
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.139
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.138
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.138
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.138
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.137
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.135
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.134
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.134
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.134
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.134
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.134
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.132
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.132
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.131
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.131
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.129
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.128
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.127
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.125
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.123
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.123
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.123
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.122
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.121
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.120
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.119
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.117
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.117
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.116
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.116
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.116
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.116
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.115
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.115
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.115
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.113
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.112
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.111
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.111
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.110
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.110
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.109
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.107
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.107
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.107
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.107
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.106
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.106
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.104
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.103
|
|
|
|
regulation of interleukin 1 beta production
|
GO:0032651 |
25 |
0.103
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.103
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.103
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.102
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.102
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.101
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.101
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.100
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.100
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.099
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.099
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.098
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.098
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.098
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.097
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.096
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.096
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.096
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.095
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.095
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.095
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.093
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.092
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.092
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.091
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.091
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.090
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.090
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.090
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.090
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.089
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.089
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.089
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.089
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.089
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.088
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.088
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.087
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.087
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.086
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.086
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.086
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.085
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.085
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.085
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.085
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.084
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.084
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.083
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.082
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.082
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.082
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.082
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.082
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.082
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.082
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.082
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.082
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.081
|
|
|
|
regulation of oligodendrocyte differentiation
|
GO:0048713 |
23 |
0.081
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.081
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.081
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.080
|
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.080
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.079
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.079
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.079
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.079
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.078
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.078
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.078
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.077
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.077
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.077
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.076
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.076
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
19 |
0.076
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.075
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.075
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.075
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.075
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.075
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.075
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.074
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.074
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.074
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.074
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.074
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.073
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.073
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.073
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.072
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.072
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.072
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.072
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.072
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.072
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.072
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.071
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.071
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.071
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.071
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.071
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.070
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.070
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.070
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.070
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.070
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.069
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.069
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.068
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.068
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.068
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.068
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.067
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.067
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.067
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.066
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.066
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.066
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.066
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.065
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.065
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.065
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.065
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.065
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.065
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.065
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.065
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.064
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.064
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.063
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.063
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.063
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.063
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.063
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.062
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.062
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.062
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.062
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.062
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.062
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.062
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.062
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.061
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.061
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.061
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.060
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.060
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.060
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.060
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.060
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.060
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.059
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.059
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.059
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.059
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.058
|
|
|
|
regulation of cell projection size
|
GO:0032536 |
6 |
0.058
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.058
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.058
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.058
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.058
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.058
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.058
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.058
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.057
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.057
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.057
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.057
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.057
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.057
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.056
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.056
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.056
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.056
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.056
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.055
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.055
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.055
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.055
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.054
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.054
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.054
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.054
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.054
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.054
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.054
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.054
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.053
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.053
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.053
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.053
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.053
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.053
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.053
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.053
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.052
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.052
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.052
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.052
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
27 |
0.052
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.052
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.052
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.052
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.052
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.051
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.051
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.051
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.051
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.051
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.051
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.051
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.051
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.050
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.050
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.050
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.050
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.049
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.049
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.049
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.049
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.049
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.049
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.049
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.049
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.049
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.048
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.048
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.047
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.047
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.047
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.047
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.047
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.046
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.046
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.046
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.046
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.046
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.046
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.046
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.046
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.046
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.046
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.046
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.046
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.046
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.045
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.045
|
|
|
|
t cell extravasation
|
GO:0072683 |
4 |
0.045
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.045
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
16 |
0.045
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.045
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.045
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.045
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.045
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.045
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.045
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.045
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.045
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.045
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.045
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.044
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.044
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.044
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.044
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.044
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.043
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.043
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.043
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.043
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.043
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.043
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.043
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.043
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.042
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.042
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.042
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.042
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.042
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.042
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.042
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.042
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.042
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.042
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.042
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.042
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.041
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.041
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.041
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.041
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.041
|
|
|
|
primitive streak formation
|
GO:0090009 |
10 |
0.041
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.041
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.041
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.041
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.041
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.041
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.041
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.041
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.040
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.040
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.040
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.040
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.040
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.040
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.040
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.040
|
|
|
|
hormone biosynthetic process
|
GO:0042446 |
16 |
0.040
|
|
|
|
epithelial mesenchymal signaling involved in prostate gland development
|
GO:0060738 |
2 |
0.040
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.040
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.040
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.040
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.040
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.040
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.039
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.039
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.039
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.039
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.039
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.039
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.039
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.039
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.039
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.038
|
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
15 |
0.038
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.038
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.038
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.038
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.038
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.038
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.038
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.038
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.037
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.037
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.037
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.037
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.037
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.037
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.037
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.037
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.037
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.037
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.037
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.037
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.037
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.037
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.037
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.036
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.036
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.036
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.036
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.036
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.036
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.036
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.036
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.036
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.036
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.036
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.036
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.036
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.036
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.036
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.035
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.035
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.035
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.035
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
29 |
0.035
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.035
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.035
|
|